List view / Grid view

Takeda Pharmaceutical Company Limited

Multiple scientific posters supporting the efficacy, safety and tolerability of once-daily Latuda® (lurasidone) are presented at the 27th ECNP Congress

22 October 2014 | By Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc

Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc. presented new evidence supporting the use of Latuda® (lurasidone), an atypical antipsychotic treatment for adults with schizophrenia, during multiple poster sessions at the 27th European College of Neuropsychopharmacology...

news

Teva and Takeda announce agreement for glatiramer acetate for multiple sclerosis treatment in Japan

4 December 2013 | By Teva Pharmaceutical Industries

Glatiramer acetate for injection is indicated for the reduction of the frequency of relapses in relapsing-remitting multiple sclerosis...

news

Takeda submits new drug application in Japan for TAK-816

27 September 2013 | By Takeda Pharmaceutical Company Limited

TAK-816 is a Haemophilus Influenzae type b (Hib) vaccine...

news

Takeda receives European marketing authorisation for three new type 2 diabetes therapies

24 September 2013 | By Takeda

Authorisation received for VipidiaTM (alogliptin) and Fixed-Dose Combinations VipdometTM (alogliptin and metformin) and IncresyncTM (alogliptin and pioglitazone)...

news

Takeda’s new investigational drug Vedolizumab granted priority review status by FDA for ulcerative colitis

6 September 2013 | By Takeda

FDA has granted Priority Review status for the Biologics License Application (BLA) for its new investigational drug vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis...

news

Takeda receives positive CHMP opinion for three new type 2 diabetes therapies, VipidiaTM (alogliptin) and fixed-dose combinations VipdometTM (alogliptin-metformin) and IncresyncTM (alogliptin-pioglitazone)

26 July 2013 | By Virgo Health

“The number of people at risk from complications associated with type 2 diabetes continues to rise..."

news

Approvals and launch update for XELJANZ® (tofacitinib citrate)

16 July 2013 | By Pfizer Inc.

Pfizer provides update on XELJANZ® (tofacitinib citrate) for the treatment of rheumatoid arthritis...

news

Takeda launches new subsidiary in Ecuador

21 March 2013 | By Takeda Pharmaceuticals International GmbH (Takeda)

Takeda announced further expansion of its presence in Latin America with the launch of its wholly-owned subsidiary in Ecuador...

news

Takeda to acquire Envoy Therapeutics, Inc.

6 November 2012 | By

Gains innovative research platform-bacTRAP technology and adds novel CNS programs...

news

Revestive® (teduglutide) receives European marketing authorization for the treatment of adults with Short Bowel Syndrome (SBS)

4 September 2012 | By F T I Consulting

The European Commission has granted European market authorization for the medicinal product teduglutide...

news

Takeda and AMAG receive a positive CHMP opinion in Europe for Rienso® (ferumoxytol)

23 April 2012 | By Takeda Pharmaceutical Company Limited

For the treatment of iron deficiency anaemia in adult chronic kidney disease patients...

news

Results from phase 3 trial of TAK-085 for the treatment of Hyperlipidemia

19 March 2012 | By Takeda Pharmaceutical Company Limited

Results presented at 76th Annual Scientific Meeting of the Japanese Circulation Society in Fukuoka...

news

Takeda announces acceptance of European Marketing Authorisation application for Peginesatide

27 February 2012 | By Weber Shandwick

An investigational compound for the treatment of anemia associated with CKD...

news

Takeda’s Edarbi® (azilsartan medoxomil) receives European marketing authorisation for the treatment of essential hypertension

8 December 2011 | By Virgo HEALTH

The European Commission has granted marketing authorisation for Edarbi® (azilsartan medoxomil)...

news

Takeda receives positive CHMP opinion in Europe for EdarbiTM (azilsartan medoxomil)

29 September 2011 | By Takeda Pharmaceutical Company Limited

The CHMP has issued a positive opinion for EdarbiTM (azilsartan medoxomil)...

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Recommended

Takeda Pharmaceutical Company Limited